This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Endoscopic Ultrasound Staging of Periampullary Neoplasms: Retrospective

This study has been completed.
Sponsor:
Information provided by:
Indiana University
ClinicalTrials.gov Identifier:
NCT00880633
First received: April 13, 2009
Last updated: February 16, 2011
Last verified: February 2011
  Purpose
The purpose of this retrospective study is to determine the degree to which a biliary stent affects EUS staging accuracy of ampullary tumors.

Condition
Periampullary Neoplasms

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: EUS Staging Accuracy of Periampullary Neoplasms: a Retrospective Review

Further study details as provided by Indiana University:

Primary Outcome Measures:
  • The presence of a biliary stent decreases EUS staging accuracy due to the intervening shadow artifacts

Study Start Date: April 2007
Study Completion Date: February 2009
Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Retrospective review of patients who have already undergone an EUS at this institution.
Criteria

Inclusion Criteria:

  • Patients will be identified retrospectively through an existing Indiana University Medical Center EUS database and pathology database.
  • Patients with and without biliary stents will be included.

Exclusion Criteria:

  • Patients that were suspected to have ampullary tumors but who were ultimately found to have a normal ampulla will be excluded.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00880633

Locations
United States, Indiana
Indiana University Hospital
Indianapolis, Indiana, United States, 46202
Sponsors and Collaborators
Indiana University
  More Information

Responsible Party: Dr. Julia LeBlanc, Indiana University
ClinicalTrials.gov Identifier: NCT00880633     History of Changes
Other Study ID Numbers: 0703-58
Study First Received: April 13, 2009
Last Updated: February 16, 2011

Keywords provided by Indiana University:
EUS
periampullary neoplasms

Additional relevant MeSH terms:
Neoplasms

ClinicalTrials.gov processed this record on June 23, 2017